Setting the Curve in Consulting to the Biopharmaceutical Industry

Representative Projects: Technical Assessment and Recommendations



Client Benefits

Nonprofit corporation holding a large minority stake in a closely held biotechnology company

Performed extensive research on novel prophylactic and therapeutic vaccine technology 

Served as an expert witness during an arbitration proceeding concerning company valuation

Technologically- and clinically relevant input into valuation models that formed the basis for the arbitration process


Pharmaceutical equities analyst for a $12 billion private asset management fund


Performed primary and secondary research on newly launched biopharmaceutical products in multiple therapeutic areas

Objective, “grassroots” feedback from product users and policy-makers to inform investment decisions

Leading health care communications agency

Collated expert nephrologists’ submissions into a series of “state-of-the-art” monographs

Peer-review quality articles for publication in support of a product-focused treatment strategy